Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00277_DB00730_nanopub.RASG8L5mVCMC52--zGjXvwLj8B22GWlLNgwYASNwKLLno#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00277_DB00730 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00277_DB00730 label "DDI between Theophylline and Thiabendazole - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Theophylline by decreasing Theophylline metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Theophylline if Thiabendazole is initiated, discontinued or dose changed. [drugbank_resource:DB00277_DB00730]" assertion.
- drugbank_resource:DB00277_DB00730 identifier "drugbank_resource:DB00277_DB00730" assertion.
- drugbank_resource:DB00277_DB00730 title "DDI between Theophylline and Thiabendazole - The strong CYP1A2 inhibitor, Thiabendazole, may increase the effects and toxicity of Theophylline by decreasing Theophylline metabolism and clearance. Monitor for changes in the therapeutic and adverse effects of Theophylline if Thiabendazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00730 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00277_DB00730 assertion.
- drugbank:DB00277 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00277_DB00730 assertion.